FLOLIPID Trademark

Trademark Overview

On Friday, July 21, 2017, a trademark application was filed for FLOLIPID with the United States Patent and Trademark Office. The USPTO has given the FLOLIPID trademark a serial number of 87537107. The federal status of this trademark filing is REGISTERED as of Tuesday, June 26, 2018. This trademark is owned by Salerno Pharmaceuticals LP. The FLOLIPID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, prescription statin medication for the treatment of coronary heart disease, elevated triglycerides, and LDL cholesterol; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquids, drops, sachets, and pharmaceutical preparations for the treatment of coronary heart disease, elevated triglycerides and LDL-cholesterol
flolipid

General Information

Serial Number87537107
Word MarkFLOLIPID
Filing DateFriday, July 21, 2017
Status700 - REGISTERED
Status DateTuesday, June 26, 2018
Registration Number5504699
Registration DateTuesday, June 26, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, prescription statin medication for the treatment of coronary heart disease, elevated triglycerides, and LDL cholesterol; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquids, drops, sachets, and pharmaceutical preparations for the treatment of coronary heart disease, elevated triglycerides and LDL-cholesterol

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 27, 2017
Primary Code005
First Use Anywhere DateWednesday, November 15, 2017
First Use In Commerce DateWednesday, November 15, 2017

Trademark Owner History

Party NameSalerno Pharmaceuticals LP
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressBrooksville, FL 34604
Party NameSalerno Pharmaceuticals LP
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressBrooksville, FL 34604
Party NameSalerno Pharmaceuticals LP
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressBrooksville, FL 34604

Trademark Events

Event DateEvent Description
Monday, June 26, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 14, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS NOT UPDATED
Tuesday, March 31, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 31, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 31, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 31, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 31, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 31, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 17, 2019TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, September 11, 2019REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Friday, September 6, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 20, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, June 27, 2019POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Tuesday, June 25, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 6, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, June 6, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, June 26, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, May 22, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 21, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 21, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 25, 2018USE AMENDMENT FILED
Thursday, May 17, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 25, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, November 12, 2017ASSIGNED TO LIE
Wednesday, November 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 26, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, October 26, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 26, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, October 26, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, October 23, 2017ASSIGNED TO EXAMINER
Thursday, July 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 25, 2017NEW APPLICATION ENTERED

Related Keywords

flolipid prescription disease heart pharmaceutical coronary triglycerides cholesterol elevated treatment preparations